Practical Guide to New Treatments for SARS-CoV-2 Infection in Dermatology Patients Being Treated With Common Immunomodulators

被引：0

作者：

Viedma-Martinez, M. ^{[1
]}

Gallo-Pineda, G. ^{[1
]}

Jimenez-Gallo, D. ^{[1
]}

机构：

[1] Hosp Puerta Mar, Serv Dermatol, Cadiz, Spain

来源：

ACTAS DERMO-SIFILIOGRAFICAS | 2023年 / 114卷 / 01期

关键词：

COVID; Immunosuppressants; Paxlovid;

D O I：

10.1016/j.ad.2022.07.020

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Immunosuppressants and immunomodulators are widely used in dermatology. Some of these drugs, however, can increase the risk of severe COVID-19. New antivirals against SARSCoV-2 have been shown to reduce progression to COVID-19 pneumonia in susceptible patients, but their availability is limited. On May 23, 2022, the Spanish Agency for Medicines and Medical Devices (AEMPS) updated its priority eligibility criteria for SARS-CoV-2 antiviral therapy. In this practical guide, we review the indications for these new drugs and provide guidance on which patients with mild to moderate COVID might benefit from their use in dermatology. (c) 2022 AEDV. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：49 / 53

页数：5

共 49 条

[31] CLINICAL CHARACTERISTICS OF NEW-ONSET IDIOPATHIC INFLAMMATORY MYOPATHIES FOLLOWING SARS-COV-2 INFECTION OR VACCINATION - ANALYSIS OF A CASE SERIES [J].

Marian, A. ;

Tamas, M. M. ;

Muntean, L. ;

Resteu, O. M. ;

Vaida-Voevod, D. A. ;

Felea, I. ;

Damian, L. ;

Filipescu, I. ;

Pamfil, C. ;

Szabo, I. ;

Simon, S. P. ;

Rednic, S. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1883-1883

[32] OUTCOMES OF SARS-COV-2 INFECTION IN PATIENTS WITH ASSOCIATED ANCA VASCULITIS. DATA FROM THE NATIONAL SAR-COVID REGISTRY [J].

Brigante, J. A. ;

Isnardi, C. A. ;

Emili, D. ;

Saurit, V. ;

Tissera, Y. ;

D'Angelo, M. E. ;

Petkovic, I. ;

Pisoni, C. ;

Quintana, R. ;

Baez, R. ;

Ornella, S. ;

Castro Coello, V. V. ;

Pera, M. ;

Haye, M. ;

Pereira, D. A. ;

Berbotto, G. ;

Alonso, G. ;

Gobbi, C. ;

Reyes, A. A. ;

Alba, P. ;

Velozo, E. ;

Gamba, M. J. ;

Tanten, R. ;

Severina, M. ;

Zelaya, D. ;

Alle, G. ;

Cogo, A. K. ;

Nieto, R. ;

Asnal, C. ;

Albiero, J. A. ;

Cosatti, M. ;

Villafane, J. ;

Maldonado, F. ;

Pons-Estel, G. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1590-1592

[33] Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy [J].

Rugge, Massimo ;

Zorzi, Manuel ;

Guzzinati, Stefano ;

Stocco, Carmen ;

Avossa, Francesco ;

Del Zotto, Stefania ;

Clagnan, Elena ;

Bricca, Ludovica ;

Dal Maso, Luigino ;

Serraino, Diego .

TUMORI JOURNAL, 2023, 109 (01) :38-46

[34] CLINICAL CHARACTERISTICS OF SARS-COV-2 INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN ARGENTINA: DATA FROM THE SAR-COVID NATIONAL REGISTRY [J].

Isnardi, C. A. ;

Roberts, K. ;

Tissera, Y. ;

Petkovic, I. ;

Berbotto, G. ;

Gobbi, C. ;

Tanten, R. ;

Cogo, A. K. ;

Asnal, C. ;

Banos, A. R. ;

Vivero, F. ;

Schmid, M. ;

Lazaro, M. A. ;

German, N. ;

Takashima, L. ;

Scafati, J. ;

Werner, M. L. ;

Casalla, L. ;

De la Vega Fernandez, S. S. ;

Castrillon Bustamante, D. ;

Rodriguez, F. ;

Moyano, S. ;

Martin, M. L. ;

Cosentino, V. ;

Herscovich, N. ;

Tralice, E. R. ;

Barbich, T. ;

Vasquez, D. L. ;

Buschiazzo, E. ;

Maid, P. ;

Ledesma, C. ;

Yohena, V. ;

Gomez, G. ;

Quintana, R. ;

Pons-Estel, G. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1894-1895

[35] RISK OF SARS-COV-2 INFECTION FOLLOWING THREE DOSES OF BNT162B2 OR MRNA-1273 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES [J].

Raptis, C. E. ;

Polysopoulos, C. ;

Berger, C. ;

Ciurea, A. ;

Andrey, D. O. ;

Lescuyer, P. ;

Maletic, T. ;

Riek, M. ;

Scherer, A. ;

Von Loga, I. ;

Safford, J. ;

Lauper, K. ;

Moeller, B. ;

Vuilleumier, N. ;

Finckh, A. ;

Rubbert-Roth, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :539-539

[36] Thrombotic Long-Term Consequences of SARS-CoV-2 Infection in Patients with Compensated Cirrhosis: A Propensity Score-Matched Analysis of a US Database [J].

Ayoub, Mark ;

Faris, Carol ;

Juranovic, Tajana ;

Aibani, Rafi ;

Koontz, Morgan ;

Chela, Harleen ;

Anwar, Nadeem ;

Daglilar, Ebubekir .

DISEASES, 2024, 12 (07)

[37] Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization [J].

Civettini, Ivan ;

Antolini, Laura ;

Brioschi, Filippo ;

Zambrotta, Giovanni Paolo Maria ;

Guglielmana, Veronica ;

Gambacorti-Passerini, Carlo .

CANCER MEDICINE, 2023, 12 (08) :9662-9667

[38] CLINICAL CHARACTERISTICS & OUTCOMES AMONG PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES AND SARS-COV-2 INFECTION: 2-YEAR DATA FROM A TERTIARY RHEUMATOLOGY CENTRE IN GREECE [J].

Gerolymatou, N. ;

Koletsos, N. ;

Zoi, T. ;

Memi, T. E. ;

Drosos, A. ;

Voulgari, P. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1888-1889

[39] BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY [J].

Olsson, E. Kihlgren ;

Ravichandran, N. ;

Nikiphorou, E. ;

Lindblom, J. ;

Saha, S. ;

Shaharir, S. S. ;

Katchamart, W. ;

Goo, P. A. ;

Traboco, L. ;

Chen, Y. M. ;

Jagtap, K. ;

Lilleker, J. B. ;

Nune, A. ;

Pauling, J. ;

Wincup, C. ;

Agarwal, V. ;

Dzifa, D. ;

Toro Gutierrez, C. E. ;

Vinicio Caballero, C. ;

Chinoy, H. ;

Agarwal, V. ;

Aggarwal, R. ;

Gupta, L. ;

Parodis, I. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :540-541

[40] Large vessel stroke in six patients following SARS-CoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease [J].

Lapergue, B. ;

Lyoubi, A. ;

Meseguer, E. ;

Avram, I. ;

Denier, C. ;

Venditti, L. ;

Consoli, A. ;

Guedon, A. ;

Houdart, E. ;

Weisenburger-Lile, D. ;

Piotin, M. ;

Maier, B. ;

Obadia, M. ;

Broucker, T. D. E. .

EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (11) :2308-2311

← 1 2 3 4 5 →